STAIDSON Trademark

Trademark Overview


On Wednesday, February 3, 2021, a trademark application was filed for STAIDSON with the United States Patent and Trademark Office. The USPTO has given the STAIDSON trademark a serial number of 90508145. The federal status of this trademark filing is REGISTERED as of Tuesday, December 14, 2021. This trademark is owned by Staidson (Beijing) Biopharmaceuticals Co., Ltd.. The STAIDSON trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, for the treatment of injury of nerve; Medicines for human purposes, for the treatment of functional constipation and/or for the intestinal cleaning preparation; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of treatment of reproductive system related diseases; Acetylsalicylic acid tablets; Medicines for human purposes, for the treatment of diabetic foot; Medicines for human purposes, for treatment of hyperuricemia; Medicines for human purposes, for hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and ...
staidson

General Information


Serial Number90508145
Word MarkSTAIDSON
Filing DateWednesday, February 3, 2021
Status700 - REGISTERED
Status DateTuesday, December 14, 2021
Registration Number6589784
Registration DateTuesday, December 14, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements


Description of MarkThe mark consists of stylized word "STAIDSON".
Goods and ServicesMedicines for human purposes, for the treatment of injury of nerve; Medicines for human purposes, for the treatment of functional constipation and/or for the intestinal cleaning preparation; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of treatment of reproductive system related diseases; Acetylsalicylic acid tablets; Medicines for human purposes, for the treatment of diabetic foot; Medicines for human purposes, for treatment of hyperuricemia; Medicines for human purposes, for hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Medicines for human purposes, for the treatment of infectious disease; Pharmaceutical preparations for the treatment of autoimmune disorders; Medicines for treating cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameStaidson (Beijing) Biopharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBEIJING 100176
CN

Party NameStaidson (Beijing) Biopharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBEIJING 100176
CN

Party NameStaidson (Beijing) Biopharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBEIJING 100176
CN

Trademark Events


Event DateEvent Description
Tuesday, December 14, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 25, 2021ASSIGNED TO EXAMINER
Thursday, May 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 6, 2021NEW APPLICATION ENTERED IN TRAM